Medtox Scientific 8-K 2011
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 13, 2011
MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
Registrant’s telephone number, including area code: (651) 636-7466
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 2.02. Results of Operations and Financial Condition
On October 13, 2011, MEDTOX Scientific, Inc. held its quarterly conference call and announced results for the third quarter ended September 30, 2011, as described in the conference call script attached as Exhibit 99.1.
- 2 -
Item 9.01. Financial Statements and Exhibits.
The following exhibit is filed as part of this report:
- 3 -
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDTOX Scientific, Inc.
Date: October 19, 2011 By: /s/ Richard J. Braun
Name: Richard J. Braun
Title: Chief Executive Officer
- 4 -
INDEX TO EXHIBITS
- 5 -